CJC-1295 with DAC 10mg Peptides
Designed for disciplined research, this peptide is prepared to support precise, consistent laboratory workflows.
This CJC-1295 with DAC lyophilized peptide vial provides a total of 10mg in a sealed research format. The formulation features the Drug Affinity Complex (DAC) modification to support extended study windows. Packaged for laboratory handling, the peptide is presented as a stable lyophilized material suitable for qualified research environments where accuracy and reproducibility are paramount.
- Each vial contains 10mg of CJC-1295 with DAC, a long-acting growth hormone releasing hormone analog widely studied for its prolonged activity profile and suitability for extended observation in controlled research models.
As a non-edible research material, the lyophilized format is selected for stability and dependable handling. Researchers value CJC-1295 with DAC for method development, assay design, and protocol validation where a long-acting GHRH analog is required for investigative purposes. The vialized presentation supports careful measurement, controlled reconstitution using appropriate laboratory techniques, and systematic application within in vitro or other approved research settings as defined by institutional protocols.
Every detail is oriented around reliability: a clean, consistent peptide identity, careful handling during production, and a format that helps maintain integrity from receipt to experiment. The focus is on minimizing variables so your data reflects the study—not uncertainties in the material. While no usage instructions are provided and no dosing is suggested, the lyophilized presentation allows qualified personnel to prepare the material according to established laboratory procedures and project-specific requirements.
Safety and trust are central to this peptide offering. Sourced and handled in the USA, each batch is produced under rigorous quality controls to support purity, consistency, and traceability. Peptide Scientific Labs maintains a research-first standard—prioritizing accurate composition, careful packaging, and transparent specifications—so you can proceed with confidence. For laboratory research use only. Not for human consumption, medical, or veterinary use.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is CJC-1295 w/ DAC?
CJC-1295 with DAC is a long-acting analog of growth hormone-releasing hormone. The DAC portion refers to a drug-affinity complex added to prolong circulation time, which is why it is usually distinguished from shorter-acting GHRH analogs. It should be presented as a research peptide for endocrine signaling studies only.
What is CJC-1295 w/ DAC typically studied for?
Researchers typically study CJC-1295 with DAC for its effect on the GH/IGF-1 axis and for sustained stimulation of endogenous growth-hormone release. In FAQ copy, the useful distinction is that it is designed for longer activity than non-DAC versions, which affects how researchers think about pulse pattern and study timing.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
